Fact CheckerSign in

NCT06723249Completed

Stingless Bee Honey Augmentation in Major Depressive Disorders

The Effect of Stingless Bee Honey on BDNF, Oxidative Stress, Depressive Symptoms and Verbal Learning and Memory in Major Depressive Disorders: A Randomized Clinical Trial

Source: ClinicalTrials.gov · Last updated 23 Dec 2025

Brief summary (registry, in English)

The goal of this clinical trial is to learn if stingless bee honey can be an augmentation supplement in Major Depressive Disorder (MDD) in adults. It will also learn about the adverse effects of the honey. The main questions it aims to answer are: 1. Is there any effect of SBH on depressive symptoms between intervention and control groups in MDD? 2. Are there any effects of SBH on BDNF between intervention and control groups in MDD? 3. Are there any effects of SBH on oxidative stress between intervention and control groups in MDD? 4. Are there any effects of SBH on verbal learning and memory between intervention and control groups in MDD? There is no placebo. Participants will: Take stingless bee honey or nothing every day for 2 months Visit the clinic once every 4 weeks for checkups and tests Report adherence and adverse effects of stingless bee honey on a self-reported online questionnaires

Status (registry)
Completed
Study type
Interventional
Enrollment
45 (actual)
First submitted
4 Dec 2024
Start date
15 Dec 2024
Primary completion date
10 Aug 2025
Lead sponsor
Hospital Universiti Sains Malaysia
Diseases
Depression
NCT number
NCT06723249

What you commit to

  • Study type: Interventional
  • Participants enrolled: 45
  • From 15 Dec 2024 to the primary completion date, 10 Aug 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Currently taking honey not limited to stingless bee honey or taken honey not limited to stingless bee honey in the past one month.

Other illness

  • Patients who with honey allergy or stingless bee honey allergy.
  • comorbidity either with generalized anxiety disorder,
  • panic disorder,
  • social anxiety disorder,
  • bipolar disorder,
  • substance-use disorder,
  • dementia,
  • Alzheimer disease,
  • hypertension,
  • chronic kidney disease

Other

  • Women in pregnancy or breast-feeding.
  • suicidal ideation or attempt,
  • diabetic,

Who the study is looking for

  • Adults with ages 18 to 65
  • with Major Depressive Disorder with scores of Beck Depression Inventory Malay version equal or more than 11

Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Hospital Universiti Sains Malaysia
Coordinator of this site? Confirm its status
Kubang KerianMalaysiaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.